Skip to main content
. 2023 Jan 19;10:1051831. doi: 10.3389/fmed.2023.1051831

TABLE 5.

Mesenchymal stem cells (MSCs) transplantation information according to patients’ stroke history.

Patient Stroke type MSC therapy after stroke MSC therapy outcomes
P1 Hemorrhagic 7 months Major
P2 Ischemic 2 weeks Major
P3 Ischemic 4 months Major
P4 Hypoxic/Ischemic encephalopathy 5 months Major
P5 Ischemic 1 year Major